A Protocol for Roux-en-Y Gastric Bypass in Rats using Linear Staplers
August 21st, 2021
5.2K views
Roux-en-Y gastric bypass (RYGB) is performed to treat obesity and diabetes. However, the mechanisms underlying RYGB's efficacy are not fully understood, and studies are limited by technical difficulty leading to high mortality in animal models. This article provides instructions on how to perform RYGB in rats with high success rates.
Overview
This article presents a detailed protocol for performing Roux-en-Y gastric bypass (RYGB) surgery in rats using surgical staplers to create a small gastric pouch, closely mimicking the human procedure. The model enables investigation of the mechanisms underlying weight loss and metabolic improvements following RYGB, with high survival rates and reproducible outcomes.
Key Study Components
Area of Science
- Bariatric surgery research
- Metabolic disease modeling
- Animal surgical models
Background
- RYGB is widely used to treat severe obesity and type 2 diabetes.
- The mechanisms of weight loss and metabolic changes post-RYGB are not fully understood.
- Factors such as reduced caloric intake, altered nutrient absorption, increased satiety, hormonal changes, bile acid metabolism, and gut microbiota shifts are implicated.
- Rat models offer better surgical tolerance and technical feasibility compared to mice, but creating a representative gastric pouch has been challenging.
Purpose of Study
- To establish a reproducible rat RYGB protocol using surgical staplers that yields a small gastric pouch similar to human anatomy.
- To provide a model for studying the physiological and metabolic effects of RYGB.
- To improve survival rates and technical accessibility for researchers.
Methods Used
- Preparation and sterile draping of rats for surgery.
- Median laparotomy and mobilization of the stomach with careful dissection and hemostasis.
- Creation of a small gastric pouch using two fires of a linear cutting stapler, removing the forestomach.
- Gastrojejunostomy and jejunojejunostomy performed with precise suturing techniques (continuous anterior, interrupted posterior).
- Leak testing and reinforcement of anastomoses as needed.
- Postoperative monitoring and comparison to sham-operated controls.
Main Results
- Rats undergoing RYGB showed significant weight loss compared to sham controls when fed a high-fat diet.
- Improved glucose tolerance was observed in the RYGB group, as measured by intraperitoneal glucose tolerance testing.
- The protocol achieved an excellent survival rate of 88.9%.
- The surgical technique is accessible and can be mastered without prior microsurgical experience.
Conclusions
- This rat RYGB protocol reliably produces a small gastric pouch and mimics human surgical anatomy.
- The model demonstrates significant weight loss and metabolic improvements, making it valuable for mechanistic studies.
- The approach is reproducible, technically accessible, and associated with high survival rates.
Frequently Asked Questions
What is the main advantage of using rats for RYGB modeling over mice?
Rats have greater physiological reserve, lower mortality rates, and allow for the use of surgical staplers, making the procedure technically easier and more representative of human RYGB.
How is the small gastric pouch created in this protocol?
A small gastric pouch is formed by firing a linear cutting stapler twice across the rat's forestomach, removing it and closely replicating the pouch size seen in human RYGB.
What are the key outcomes measured in this model?
Key outcomes include postoperative weight loss, glucose tolerance (via intraperitoneal glucose tolerance testing), and survival rates compared to sham-operated controls.
Why is removal of the rat forestomach considered physiologically appropriate?
The rat forestomach lacks glands, so its removal does not significantly alter the physiological outcomes relevant to RYGB studies.
What suturing techniques are used for the anastomoses?
The anterior side of each anastomosis is sutured continuously, while the posterior side is sutured with interrupted stitches to prevent stricture or stenosis.
Can this surgical protocol be performed without prior microsurgical experience?
Yes, the protocol is designed to be accessible and can be mastered without previous microsurgical training.
What is the survival rate achieved with this protocol?
The protocol achieves an excellent survival rate of 88.9% following RYGB surgery in rats.
Executive Industry Relevance
The rat Roux-en-Y gastric bypass (RYGB) model using linear staplers provides a reproducible, physiologically relevant platform for dissecting the mechanisms underlying bariatric surgery-induced weight loss and metabolic changes. This model enables high-confidence hypothesis testing around metabolic pathways, satiety signaling, and nutrient absorption, supporting early discovery and mechanistic de-risking in metabolic disease research. Its technical accessibility and high survival rates facilitate robust preclinical evaluation and cross-study comparability.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of metabolic and hormonal pathways implicated in obesity and diabetes.
- Supports functional validation of targets involved in satiety, glucose regulation, and bile acid metabolism.
- Facilitates mechanistic de-risking by isolating surgical and physiological variables in a controlled model.
- Provides predictive confidence for downstream translational studies.
Screening & Assay Development
- Establishes a validated in vivo system for evaluating candidate interventions affecting weight and glucose homeostasis.
- Delivers reproducible, quantitative outputs such as weight loss and glucose tolerance metrics.
- Enables standardization of surgical and metabolic endpoints for cross-study comparison.
- Prepares a robust platform for screening metabolic modulators or device prototypes.
Translational & Preclinical Research
- Aligns preclinical findings with human RYGB physiology by mimicking surgical anatomy and outcomes.
- Supports continuity from mechanistic discovery to preclinical validation of metabolic targets.
- Reduces translational risk by providing a model with high survival and technical reproducibility.
- Facilitates biomarker discovery and validation in a disease-relevant system.
Pipeline & Workflow Integration
This rat RYGB protocol integrates into the discovery-to-preclinical continuum for metabolic disease research, bridging early mechanistic studies and translational validation.
- Discovery Biology: Enables rigorous hypothesis testing of metabolic and hormonal pathways post-RYGB.
- Screening: Provides a standardized, reproducible in vivo assay for evaluating metabolic interventions.
- Analytics: Generates quantitative readouts such as weight change and glucose tolerance for comparative analysis.
- Translational Research: Offers a physiologically relevant model for aligning preclinical and clinical metabolic endpoints.
- Enterprise Reuse: Establishes a reusable, accessible platform for ongoing metabolic and bariatric research programs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in metabolic disease modeling.
- Operational Value: Delivers standardization, reproducibility, and scalability for in vivo metabolic studies.
- Strategic Value: Supports informed go/no-go decisions and capital-efficient portfolio advancement.
- Portfolio Impact: Enables risk-adjusted prioritization of metabolic targets and interventions.
Implementation Considerations
- Requires surgical proficiency and familiarity with rodent models.
- Needs access to linear staplers, microsurgical instruments, and metabolic phenotyping infrastructure.
- Demands cross-team standardization of surgical technique and metabolic assessments.
- Adaptation may be needed for different rat strains or metabolic backgrounds.
- Limitations include species-specific physiology and the need for rigorous postoperative monitoring.
Biopharma FAQs
Why is null hypothesis testing critical for RYGB target validation?
Null hypothesis testing in the rat RYGB model allows teams to rigorously assess whether observed metabolic changes are attributable to the surgical intervention rather than confounding variables, supporting robust target validation and mechanistic clarity.
How does independent variable isolation enhance RYGB discovery workflows?
By controlling surgical technique and physiological endpoints, the protocol isolates key variables such as pouch size and limb configuration, enabling precise attribution of metabolic effects and supporting discovery-stage hypothesis refinement.
What do quantitative dependent variable measurements enable in RYGB studies?
Quantitative outputs like weight loss and glucose tolerance provide objective metrics for comparing intervention groups, facilitating data-driven decision-making and cross-study reproducibility in metabolic research pipelines.
Why are replication requirements important for cross-functional RYGB studies?
Replication ensures that observed metabolic and physiological effects are consistent and reproducible, enabling reliable data sharing and collaboration across discovery, translational, and preclinical teams.
What statistical analysis capabilities are needed before RYGB protocol implementation?
Teams must be equipped to perform statistical comparisons of weight, glucose tolerance, and survival data to validate findings, assess significance, and inform go/no-go decisions in metabolic disease research portfolios.
Chapters in this video
0:13
Introduction
0:39
Preparation of Animals and Operative Setup
1:07
Median Laparotomy
1:36
Mobilizing the Stomach
2:42
Identify and Divide the Jejunum
3:52
Stapling the Stomach
4:49
Gastrojejunostomy
8:24
Jejunojejunostomy
9:56
Reposition the Bowel and Stomach
10:20
Abdominal Closure
10:47
Results
11:28
Conclusion
